Trials / Completed
CompletedNCT00721188
Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients
Single-Dose Pharmacokinetics of Venofer (Iron Sucrose Injection) in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients Receiving or Not Receiving Erythropoiesis Stimulating Agents (ESA's)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- American Regent, Inc. · Industry
- Sex
- All
- Age
- 12 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to assess the pharmacokinetics of Venofer (Iron Sucrose Injection) in NDD-CKD pediatric patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Venofer | Single dose of 7mg intravenous (IV) of iron per kg of body weight for a maximum of 200mg iron IV. |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2008-07-01
- Completion
- 2010-01-01
- First posted
- 2008-07-23
- Last updated
- 2018-02-20
- Results posted
- 2011-03-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00721188. Inclusion in this directory is not an endorsement.